Barclays raised the firm’s price target on Kimberly-Clark to $132 from $124 and keeps an Equal Weight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- M&A News: Kimberly-Clark (NYSE:KMB) to Offload PPE Unit to Australia’s Ansell
- Ansell to acquire Kimberly-Clark’s PPE business for $640M
- Australian Stocks: Ansell (ANN) to Acquire Kimberly-Clark’s PPE Unit, Shares on Trading Halt
- Palantir downgraded, CyberArk initiated: Wall Street’s top analyst calls
- Kimberly-Clark price target raised to $132 from $127 at Deutsche Bank
Questions or Comments about the article? Write to editor@tipranks.com